PTSD

Politico reports on efforts to 'warp-speed' access to psychedelic drugs, a reference to accelerating the regulatory approval or availability of substances such as psilocybin or MDMA for mental health treatment. Psychedelic therapy has drawn growing attention as a possible response to depression and PTSD, and the story is prompting debate over whether fast-tracked access is justified by the evidence or risks moving ahead of the science.